HALO logo
halo search icon
Aura Biosciences Inc

US$7.47

Price Change Indicator
0.08 (1.08%)
Aura Biosciences Inc
AURA · NAS

Aura Biosciences Inc

Start Trading AURA for Free

US$7.47

Price Arrow0.08 (1.08%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumHALO MomentumVolume Spike
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Aura Biosciences Inc Overview

AURA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AURA

icon

Website

Aura Biosciences Inc

icon

Telephone

1.617.500.8864

icon

Address

80 Guest Street, Boston, MA 02135

Description

Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.

AURA Price Chart

Key Stats

Market Cap

US$764.03M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.73 - 9.53

Trade Value (12mth)

US$452,722.00

1 week

-4.52%

1 month

-0.67%

YTD

39.43%

1 year

23.99%

All time high

26.16

Key Fundamentals

EPS 3 yr Growth

-10.30%

EBITDA Margin

0.00%

Operating Cashflow

-$85m

Free Cash Flow Return

-53.20%

ROIC

-66.70%

Interest Coverage

0.00

Quick Ratio

8.10

Other Data

Shares Outstanding (Fully Diluted)

67m

HALO Sector

Healthcare

Next Company Report Date

30-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AURA Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
12 May 26
06 May 26

AURA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.93-1.75-1.76locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.93-1.75-1.76locklocklock
Growth
 %locklocklocklock1.89.2-0.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Aura Biosciences Inc (AURA:NAS)?
Halo FAQ
The current share price of Aura Biosciences Inc (AURA:NAS) is USD$7.47.
What is the 52-week high share price for Aura Biosciences Inc (AURA:NAS)?
Halo FAQ
The 52-week high share price for Aura Biosciences Inc (AURA:NAS) is USD$9.53.
What is the 52-week low share price for Aura Biosciences Inc (AURA:NAS)?
Halo FAQ
The 52-week low share price for Aura Biosciences Inc (AURA:NAS) is USD$4.73.
What is the dividend yield for Aura Biosciences Inc (AURA:NAS)?
Halo FAQ
Aura Biosciences Inc (AURA:NAS) does not pay a dividend.
What was Aura Biosciences Inc (AURA:NAS) last dividend payment?
Halo FAQ
Aura Biosciences Inc (AURA:NAS) does not pay a dividend.
What is the franking level for Aura Biosciences Inc (AURA:NAS)?
Halo FAQ
Aura Biosciences Inc (AURA:NAS) has a franking level of 0.00%.
In which sector is Aura Biosciences Inc (AURA:NAS) classified?
Halo FAQ
Aura Biosciences Inc (AURA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial